Drug treatment Brenna

Borna Daro Darman Knowledge-Based Company started its activity in 2014 in the field of production of pharmaceutical and medical biotechnology products, with the aim of producing new pharmaceutical products based on recombinant proteins and biosimilar drugs. This company, by utilizing capable experts in the research and development department and localization of all production stages, seeks to provide biological and biosimilar drugs required for domestic consumption as well as their export. With ten years of research by the founders and researchers of Borna Daro Darman, EGF and FGF growth factors with high purity and biological activity have been produced. These growth factors are used to produce wound healing products, tissue engineering products and cosmetic products.